| Dr Michael S Murphy, MD | |
|
1400 Front Ave, Suite 100, Lutherville, MD 21093-5300 | |
| (410) 296-6232 | |
| (410) 821-5943 |
| Full Name | Dr Michael S Murphy |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 40 Years |
| Location | 1400 Front Ave, Lutherville, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760446991 | NPI | - | NPPES |
| 903A | Other | MD | CAREFIRST MARYLAND |
| DE5302 | Other | MD | RAILROAD MEDICARE |
| J848 | Other | MD | CAREFIRST DC |
| 331950400 | Medicaid | MD | |
| DC8030 | Other | MD | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | D0046474 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Union Memorial Hospital | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Agape Physical Therapy And Sports Rehabilitation Lp | 3870741390 | 147 |
| Greater Chesapeake Hand Specialists, P.a. | 5092727206 | 9 |
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
New research from the University of Southampton has found that working or travelling on an underground railway for a sustained period of time could have health implications.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved the establishment of nine new Collaborative Research Centres (CRCs).
Beckman Coulter welcomes FDA announcement for received regulatory clearance to market its ClearLLab reagents for in vitro diagnostic use in the US.
Glioblastoma is a serious and incurable brain cancer. Patients receiving this diagnosis typically have 11-20 months to live. One of the main difficulties in treating this cancer is that its cells quickly build up a resistance to chemotherapy.
Once a vague scapegoat for a variety of ills, increasing evidence suggests a condition known as "leaky gut" - in which microbes and other molecules seep out of the intestines - may be more common, and more harmful, than previously thought.
› Verified 9 days ago
| Entity Name | Greater Chesapeake Hand Specialists, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104852359 PECOS PAC ID: 5092727206 Enrollment ID: O20060706000167 |
News Archive
New research from the University of Southampton has found that working or travelling on an underground railway for a sustained period of time could have health implications.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved the establishment of nine new Collaborative Research Centres (CRCs).
Beckman Coulter welcomes FDA announcement for received regulatory clearance to market its ClearLLab reagents for in vitro diagnostic use in the US.
Glioblastoma is a serious and incurable brain cancer. Patients receiving this diagnosis typically have 11-20 months to live. One of the main difficulties in treating this cancer is that its cells quickly build up a resistance to chemotherapy.
Once a vague scapegoat for a variety of ills, increasing evidence suggests a condition known as "leaky gut" - in which microbes and other molecules seep out of the intestines - may be more common, and more harmful, than previously thought.
› Verified 9 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
New research from the University of Southampton has found that working or travelling on an underground railway for a sustained period of time could have health implications.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved the establishment of nine new Collaborative Research Centres (CRCs).
Beckman Coulter welcomes FDA announcement for received regulatory clearance to market its ClearLLab reagents for in vitro diagnostic use in the US.
Glioblastoma is a serious and incurable brain cancer. Patients receiving this diagnosis typically have 11-20 months to live. One of the main difficulties in treating this cancer is that its cells quickly build up a resistance to chemotherapy.
Once a vague scapegoat for a variety of ills, increasing evidence suggests a condition known as "leaky gut" - in which microbes and other molecules seep out of the intestines - may be more common, and more harmful, than previously thought.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael S Murphy, MD 1400 Front Ave, Suite 100, Lutherville, MD 21093-5300 Ph: (410) 296-6232 | Dr Michael S Murphy, MD 1400 Front Ave, Suite 100, Lutherville, MD 21093-5300 Ph: (410) 296-6232 |
News Archive
New research from the University of Southampton has found that working or travelling on an underground railway for a sustained period of time could have health implications.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved the establishment of nine new Collaborative Research Centres (CRCs).
Beckman Coulter welcomes FDA announcement for received regulatory clearance to market its ClearLLab reagents for in vitro diagnostic use in the US.
Glioblastoma is a serious and incurable brain cancer. Patients receiving this diagnosis typically have 11-20 months to live. One of the main difficulties in treating this cancer is that its cells quickly build up a resistance to chemotherapy.
Once a vague scapegoat for a variety of ills, increasing evidence suggests a condition known as "leaky gut" - in which microbes and other molecules seep out of the intestines - may be more common, and more harmful, than previously thought.
› Verified 9 days ago
Dr. Christopher Lee Forthman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Front Ave, Suite 100, Lutherville, MD 21093 Phone: 410-296-6232 Fax: 410-821-5943 | |
Dr. Ryan M Zimmerman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Front Ave, Suite 100, Lutherville, MD 21093 Phone: 410-296-6232 Fax: 410-821-5943 | |
Dr. Keith A. Segalman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Front Ave, Suite 100, Lutherville, MD 21093 Phone: 410-296-6232 Fax: 410-821-5943 | |
Dr. Neal Bruce Zimmerman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Front Ave, Suite 100, Lutherville, MD 21093 Phone: 410-296-6232 Fax: 410-821-5943 | |
Edward George Mcfarland, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10753 Falls Rd, Lutherville, MD 21093 Phone: 410-583-2727 | |
Dr. John Russell Moore, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1400 Front Ave, Suite 100, Lutherville, MD 21093 Phone: 410-296-6232 Fax: 410-296-7363 | |
Dr. Raymond A. Wittstadt, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Front Ave, Suite 100, Lutherville, MD 21093 Phone: 410-296-6232 Fax: 410-821-5943 |